Latest Breaking News On - Company new drug application - Page 14 : comparemela.com

Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate Program

LOS ALTOS, Calif., June 29, 2023 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), t.

United statesShalabh guptaDrug administrationCompany new drug applicationCompany or unicyciveGlobenewswire incShire international licensingUnicycive therapeutics incExchange commissionReason researchNew drug applicationReference listed drugEnd stage renal diseaseLanthanum dioxycarbonatePrivate securities litigation reform actRisk factor

Unicycive Therapeutics (UNCY) Provides Regulatory Update on Lanthanum Dioxycarbonate Program

Unicycive Therapeutics (UNCY) Provides Regulatory Update on Lanthanum Dioxycarbonate Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesShalabh guptaReason researchShire international licensingUnicycive therapeutics incCompany new drug applicationExchange commissionDrug administrationCompany or unicyciveUnicycive therapeuticsNew drug applicationReference listed drugEnd stage renal diseaseLanthanum dioxycarbonatePrivate securities litigation reform actRisk factor

Unicycive Therapeutics Provides Regulatory Update on

LOS ALTOS, Calif., June 29, 2023 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing.

United statesShalabh guptaUnicycive therapeutics incReason researchCompany new drug applicationDrug administrationExchange commissionCompany or unicyciveShire international licensingNew drug applicationReference listed drugEnd stage renal diseaseLanthanum dioxycarbonatePrivate securities litigation reform actRisk factorAnnual report

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesShalabh guptaUnicycive therapeutics incReason researchDrug administrationCompany new drug applicationExchange commissionCompany or unicyciveShire international licensingNew drug applicationReference listed drugEnd stage renal diseaseLanthanum dioxycarbonatePrivate securities litigation reform actRisk factorAnnual report

Bragar Eagel & Squire, P C Is Investigating Zai Lab, Hayward, Ascendis, and Alvotech and Encourages Investors to Contact the Firm - Ascendis Pharma (NASDAQ:ASND), Alvotech (NASDAQ:ALVO)

NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zai Lab Limited (Zai Lab Limited), Hayward

South carolinaUnited statesNew yorkBrandon walkerAscendis pharmaMarion passmoreBragar eagel squireExchange commissionHolding foreign companies accountableZai labUs food drug administrationHayward holdingsDrug administrationZai lab limitedCompany new drug applicationHayward holdings inc